Condition
Lung Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 27 Lung Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (24), Denmark (1), China (1)). By phase: Phase 2 (4), Phase 1/2 (1), Early Phase 1 (1). The most active sponsors are M.D. Anderson Cancer Center (7), Mayo Clinic (3), Fred Hutchinson Cancer Center (3). There are also 6 NIH-funded research projects on Lung Carcinoma, with $2.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 27Clinical trials
- 6NIH research projects
- 4Countries
Newest Lung Carcinoma clinical trials
All recruiting trials (27)
-
Couples Coping Together Against Cancer: A Feasibility and Acceptability Look
This observational study tests whether a brokered program for patients with cancer and their partners is feasible and acceptable, and whether it may reduce distress over time.
-
Lung Toolkit: a tailored education program to help AI/AN cigarette smokers learn about lung cancer and screening
A Lung Toolkit education program is tested to see if it improves knowledge about lung cancer and screening among American Indian and Alaska Native cigarette smokers aged 50–80.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
Restorative Justice–Based Lung Cancer Screening Support for Black Individuals to See if Screening Increases Uptake
This trial tests a restorative justice–based decision-making support to see if it increases lung cancer screening among Black adults who smoke or recently stopped.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Support for Veterans with lung cancer.
This study will test whether weekly phone support from a trained lay health worker can improve quality of life for Veterans who are newly diagnosed with lung cancer or who finished treatment within the past year.
-
Tailored Patient Navigation to Boost Lung Cancer Screening in Tribal Communities
This trial tests whether customized patient navigation can help American Indian and Alaska Native people in western Washington start and complete lung cancer screening.
-
SKB518 treatment for people with lung cancer
This trial will test whether SKB518 given alone is safe and can shrink tumors in adults with non-small cell or small cell lung cancer.
-
Vanguard: a new blood test approach to screen for multiple cancers
This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.
-
Using fucoidan to prevent fatigue in cancer patients undergoing chemotherapy
This study tests if a seaweed supplement called fucoidan can help cancer patients undergoing chemotherapy feel less tired.
-
New tool to help lung cancer patients understand their illness better
This study tests a new tool to help lung cancer patients better understand their illness and treatment options compared to regular care.
-
Imaging study using two antibody fragments in patients with solid tumors
This study is testing two special antibody fragments in people with solid tumors to see how well they target cancer cells and how they move through the body.
-
Evaluating genetic testing for suspected lung cancer
This study is testing if robotic biopsies can help find genetic markers in patients suspected of having lung cancer to improve future treatments and share important results with them.
-
Coaching or self-monitoring to improve physical function in older lung cancer surgery patients and their caregivers
This study is testing whether phone coaching or self-monitoring can help older lung cancer surgery patients and their caregivers improve their physical function after surgery.
-
Using advocates to boost lung cancer screening rates
This study is testing if having advocates and support can help more people get screened for lung cancer by addressing their concerns and encouraging them to share information with others.
-
Lung cancer screening for high-risk Black women
This study is testing if low-dose CT scans for lung cancer are acceptable and helpful for high-risk Black women who have a history of smoking.
-
AI-guided radiation therapy for lung tumors
This study is testing if using artificial intelligence to personalize radiation treatment can help people with lung tumors get better results and reduce the chance of their cancer coming back.
-
Evaluating heart damage from radiation in lung and esophageal cancer patients
This study is testing how radiation treatment for lung and esophageal cancer affects the heart and aims to find ways to reduce heart damage during therapy.
-
Increasing Lung Cancer Screening for Smokers
This study is testing whether teaching doctors and patients about lung cancer screening can help more smokers get screened for the disease.
-
Using canakinumab to prevent lung cancer in high-risk patients
This study is testing if a medication called canakinumab can help prevent lung cancer in people who have high-risk lung nodules.
-
Improving recovery after lung surgery through walking and monitoring
This study is testing how walking and sleep habits can help lung cancer patients recover better after surgery by comparing standard care with added support from a Fitbit or early walking encouragement.
-
Investigating the rise of robotic lung surgeries
This study looks at how often robotic surgeries for lung cancer are being done compared to traditional methods to see how they affect patient outcomes.
-
Educating smokers about lung cancer screening through quitlines
This study tests whether training call center staff to give information about lung cancer screening can help heavy smokers aged 55-80 learn more and get screened.
-
Using patient-derived cancer models to address health disparities in cancer treatment
This study is trying to create and test cancer models from patients, especially those from minority backgrounds, to see how we can improve cancer treatments for bladder, gastric, liver, and lung cancers.
-
Using a special dye to detect lung cancer during surgery
This study is testing a special dye to see if it can help doctors find lung cancer more easily during surgery.
-
CPAP versus deep inspiration breath hold to reduce lung tumor motion during SBRT
This test compares whether a CPAP breathing device or holding a deep breath better reduces tumor movement during SBRT for people with lung cancer.
-
Collecting data on side effects of proton therapy for cancer treatment
This study is trying to learn about the side effects that cancer patients experience after receiving proton therapy to help improve future treatments.
NIH-funded research (6)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeting immune vulnerabilities in small cell lung cancer
A physician-scientist is undergoing a five-year training program to understand how immune cells interact with small cell lung cancer and to build skills for a future independent lab career.
-
Investigating immune weaknesses in small cell lung cancer
This study is looking at how the immune system works with small cell lung cancer to find new ways to help it fight the disease, and it's designed for patients who want to learn more about potential treatments.
-
How small cell lung cancer cells switch between different states
This research looks at how cells inside small cell lung cancer change into different types and how those changes affect treatment for people with SCLC.
-
Understanding how small cell lung cancer adapts and resists treatment
This study is looking at small cell lung cancer to understand why it grows so quickly and resists treatment, using special models from patients to find new ways to improve care for people facing this tough disease.
-
A new treatment for squamous cell lung cancer using targeted therapy
This study is testing a new treatment for squamous cell lung cancer that uses a special drug designed to deliver chemotherapy directly to cancer cells, which could help patients feel better and live longer while protecting healthy tissues.
-
Combining targeted therapies to treat difficult lung cancer cases
This study is testing a new way to treat advanced non-small cell lung cancer by using a special self-injectable medicine that targets specific proteins causing the cancer, with the hope of making treatments work better for patients.
Related topics
Quick answers
How many Lung Carcinoma clinical trials are recruiting right now?
27, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (24 trials), Denmark (1 trial), China (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.